Arrowhead Pharmaceuticals Inc Annual Shareholders Meeting Transcript
The line is now open for the 2021 Annual Meeting of Stockholders of Arrowhead Pharmaceuticals.
Good morning, and thank you for joining our virtual meeting of stockholders. I am Christopher Anzalone, the President, CEO and Director of Arrowhead and will be serving as Chairman for today's meeting. The polls are open for voting. If you have a question, you may submit it via the medium portal.
With us today are Doug Given, Chairman of the Board; Mike Perry, Lead Director and Chair of the Compensation Committee; Will Waddill, Director and Chair of the Audit Committee; Mauro Ferrari, Director; Oye Olukotun, Director; also present are the following members of management; Ken Myszkowski, Chief Financial Officer; Patrick O'Brien, General Counsel and Corporate Secretary; Vince Anzalone, VP of Investor Relations; and representatives of Rose, Snyder & Jacobs, our independent registered public accounting firm. I hereby call this meeting to order. It has been duly called and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |